Inilunsad ng VitaDAO ang biotech firm para sa medikal na pananaliksik
Pananalapi Inilunsad ng VitaDAO ang biotech firm para sa medikal na pananaliksik 22 minuto ang nakalipas Balita ng Ethereum ng Bitcoin A decentralized autonomous organization (DAO), VitaDAO, is pushing the boundaries of life extension by founding a biotech company dedicated to cutting-edge research in the treatment of cancer and age-related diseases. VitaDAO, a community-driven collective with a primary goal of funding and advancing early-stage longevity research, has unveiled Matrix Biosciences in partnership with renowned biologist Vera Gorbunova. Professor Gorbunova, hailing from the University of Rochester, is credited with the discovery of cancer-resistant traits in the naked mole-rat. VitaDAO unveils Matrix Biosciences The driving force behind Matrix Biosciences is to bridge the gap between DAO-based research and real-world applications. Unlike VitaDAOs decentralized nature, Matrix Biosciences will operate as a centralized entity, resembling a traditional company. VitaDAO will hold the majority of shares in this newly formed biotech firm, which will be obligated to provide quarterly reports, aligning with conventional investment structures. Todd White, a core member of VitaDAO, emphasized their mission to demonstrate the effective coexistence of blockchain technology with the biotech industry. He acknowledged the strict regulatory environment surrounding medicine and healthcare and mentioned that both VitaDAO and Matrix Biosciences are proactively working with regulators. White stressed









